These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type. Davies P Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427 [No Abstract] [Full Text] [Related]
4. Neurotransmitters in the brains of patients with dementia disorders. Gottfries CG Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668 [No Abstract] [Full Text] [Related]
7. Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type. Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL Exp Brain Res; 1982; Suppl 5():153-7. PubMed ID: 6129994 [No Abstract] [Full Text] [Related]
8. Neurotransmitter and neuropeptide systems in Alzheimer-type dementia. Perry EK; Perry RH Exp Brain Res; 1982; Suppl 5():140-5. PubMed ID: 6185355 [No Abstract] [Full Text] [Related]
9. Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL). Argentiero V; Tavolato B J Neurol; 1980; 224(1):53-8. PubMed ID: 6157799 [TBL] [Abstract][Full Text] [Related]
11. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286 [TBL] [Abstract][Full Text] [Related]
12. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Davies P Brain Res; 1979 Aug; 171(2):319-27. PubMed ID: 37989 [TBL] [Abstract][Full Text] [Related]
13. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Perry EK; McKeith I; Thompson P; Marshall E; Kerwin J; Jabeen S; Edwardson JA; Ince P; Blessed G; Irving D Ann N Y Acad Sci; 1991; 640():197-202. PubMed ID: 1723256 [TBL] [Abstract][Full Text] [Related]
14. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Perry EK; Tomlinson BE; Blessed G; Bergmann K; Gibson PH; Perry RH Br Med J; 1978 Nov; 2(6150):1457-9. PubMed ID: 719462 [TBL] [Abstract][Full Text] [Related]
15. Laboratory examinations correlated with severity of dementia. Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434 [TBL] [Abstract][Full Text] [Related]
16. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Crystal HA; Davies P J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease. Kaye JA; May C; Atack JR; Daly E; Sweeney DL; Beal MF; Kaufman S; Milstien S; Friedland RP; Rapoport SI Ann Neurol; 1988 Nov; 24(5):647-50. PubMed ID: 2462403 [TBL] [Abstract][Full Text] [Related]
19. Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia. Rossor MN; Iversen LL; Mountjoy CQ; Roth M; Hawthorn J; Ang VY; Jenkins JS Lancet; 1980 Dec 20-27; 2(8208-8209):1367-8. PubMed ID: 6109178 [No Abstract] [Full Text] [Related]
20. [Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid]. Guard O; Renaud B; Chazot G Encephale; 1976; 2(4):293-303. PubMed ID: 1001240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]